Bibliographic Details
| Title: |
Clozapine in the Spotlight: Understanding the Recent Clozapine REMS Changes and a Research Update for 2025. |
| Authors: |
Mills, Jeremy, Long, Anna Catherine |
| Source: |
Issues in Mental Health Nursing. Jun2025, Vol. 46 Issue 6, p633-637. 5p. |
| Subjects: |
Psychiatry, Patient safety, Risk management in business, Antipsychotic agents, United States. Food & Drug Administration, Schizophrenia, Pharmacy information services, Drug approval, Clozapine, Neutropenia |
| Abstract: |
The article discusses the abrupt discontinuation of the Clozapine REMS safety program, which caused widespread disruption for clinicians and pharmacies managing treatment-resistant schizophrenia. Topics include the implications of REMS removal, ongoing blood monitoring requirements, and barriers to clozapine access, highlighting challenges faced by University of Tennessee College of Nursing and Peninsula Outpatient Pharmacy professionals in ensuring patient safety and medication continuity. |
| Database: |
Psychology and Behavioral Sciences Collection |
